Achieving Clinical Trial Diversity Through Actionable Steps

Suzanne H.
Suzanne H.

Sales and Marketing

The medical community and cultural opinion agree: clinical trials need diversity. It’s our job to serve affected populations, but we cannot do that if we don’t have an appropriate representation of these populations in our research. Minorities are often more at risk for the disease yet are egregiously underrepresented in clinical trials. Understanding why and how minority populations are underrepresented can lead us to define actionable steps that organizations of all sizes can take to help solve the problem.

“Perhaps the most straightforward action we can take is addressing the financial challenges prospective participants face. Informing underserved populations about compensation and travel stipends that are available can garner participation. And, investing in increasing those funds can also improve recruitment by addressing the income and resource gap.”

Scott continues to elaborate on actionable ways to improve trial diversity and the increased responsibility we as an industry have to make diversity a priority in the June issue of Pharmaceutical Outsourcing.

Key Topics

  • Understanding the Lack of Diversity in Clinical Trials
  • Manageable Steps for Improving Minority Recruitment and Participation
  • Challenges of Achieving Diversity in Rare Disease Trials
  • Other Diversity-Increasing Benefits of Patient Coordinators
  • The Lasting Impact of Purposeful Representation in Clinical Trials
  • Diversity is Our Responsibility

Click to read more in the original article featured on

Improve patient diversity in your next clinical trial

Voice of the Patient Research

View the results of our recent research to explore how effective patient support strategies can reduce barriers, increase retention, and improve outcomes in rare disease clinical trials in our latest eBook.

Voice of the patient